Alexander Turchin Selected Research

Hemorrhage

1/2011

Unexpected effects of unintended consequences: EMR prescription discrepancies and hemorrhage in patients on warfarin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexander Turchin Research Topics

Disease

5	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 02/2015
4	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 02/2008
4	Hypertension (High Blood Pressure) 02/2015 - 12/2009
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2016
3	Hyperglycemia 01/2021 - 02/2008
3	Diabetes Mellitus 01/2020 - 02/2008
3	Stroke (Strokes) 05/2018 - 01/2017
3	Coronary Artery Disease (Coronary Atherosclerosis) 05/2018 - 01/2016
2	Myocardial Infarction 01/2020 - 01/2018
2	Atrial Fibrillation 07/2017 - 01/2017
2	Neoplasms (Cancer) 10/2016 - 01/2015
2	Chronic Renal Insufficiency 02/2015 - 12/2014
1	Weight Loss (Weight Reduction) 01/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Insulin Resistance 01/2021
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2021
1	Aortic Valve Stenosis (Aortic Stenosis) 11/2020
1	Unstable Angina 01/2020
1	Chest Pain (Chest Pains) 01/2020
1	Myalgia 05/2018
1	Muscular Diseases (Myopathy) 05/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Calciphylaxis 08/2014
1	Hypoalbuminemia 01/2013
1	Hypercalcemia (Milk Alkali Syndrome) 01/2013
1	Hemorrhage 01/2011
1	Drug-Related Side Effects and Adverse Reactions 04/2009
1	Confusion (Bewilderment) 11/2006
1	Inflammation (Inflammations) 07/2006
1	Fibrosis (Cirrhosis) 07/2006

Drug/Important Bio-Agent (IBA)

5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022 - 01/2016
4	Insulin (Novolin)FDA Link 01/2021 - 05/2013
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2015
2	CalciumIBA 01/2021 - 08/2014
2	AnticoagulantsIBA 07/2017 - 01/2017
2	LipidsIBA 12/2014 - 12/2009
2	Antihypertensive Agents (Antihypertensives)IBA 05/2014 - 02/2008
2	Warfarin (Coumadin)FDA LinkGeneric 01/2013 - 01/2011
2	Glucose (Dextrose)FDA LinkGeneric 09/2011 - 02/2008
1	Nonesterified Fatty Acids (NEFA)IBA 01/2021
1	Angiotensin IIIBA 01/2021
1	Advanced Glycation End ProductsIBA 01/2021
1	Lipoprotein(a)IBA 11/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Hormones (Hormone)IBA 10/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2016
1	antineoplaston A10 (A 10)IBA 02/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	1 alpha-hydroxyergocalciferol (doxercalciferol)FDA Link 01/2013
1	paricalcitol (Zemplar)FDA Link 01/2013
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2013
1	Hemoglobins (Hemoglobin)IBA 09/2011
1	CholesterolIBA 09/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 09/2011
1	LDL CholesterolIBA 09/2011
1	oxidized low density lipoproteinIBA 09/2011
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2008
1	AldosteroneIBA 07/2006

Therapy/Procedure

10	Therapeutics 03/2022 - 05/2013
3	Glycemic Control 01/2021 - 01/2018
1	Patient Readmission 01/2020
1	Cardiac Rehabilitation 01/2020
1	Renal Dialysis (Hemodialysis) 08/2014
1	Medication Reconciliation 04/2009
1	Patient Admission (Patient Admissions) 02/2008
1	Medication Errors (Medication Error) 11/2006